FDA permits marketing of AI-based device to detect diabetic retinopathy
The FDA has permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy...
List view / Grid view
News
Vaccine suppresses peanut allergies in mice
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
First-in-Human trial of cannabis-based therapy for Parkinson’s initiated
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
Second patent awarded for AdvantaPure®’s AdvantaPass® clean room wall pass-through system
Significant Improvements Prompt Issuance...
Injectable sensor could provide unobtrusive, long-term alcohol monitoring
Engineers have developed a miniature, ultra-low power injectable biosensor that could be used for continuous, long-term alcohol monitoring...
Simultaneous chemo and immunotherapy is effective in metastatic bladder cancer
Researchers have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumours have certain genetic mutations...
Bruker launches new FT-IR R&D Spectrometer INVENIO™
Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications...
Bruker introduces the new CTX™ Portable XRF Analyzer
Bruker today introduces the new CTX™ X-ray fluorescence (XRF) elemental analyzer. The portable Counter Top XRF (CTX) is small, light-weight, safety-interlocked, and battery operated. At less than 7 kilograms in weight, the self-contained CTX is truly portable, and has a small footprint of 14 cm in width...
Novel drug shows promise against acute myeloid leukaemia
First of a new class of anti-cancer agents to reach clinical trials...
Robotics takes mass spec to the third dimension for pharma applications
Scientists report that by combining a robotic arm and mass spectrometry can potentially open up new branches of pharmaceutics...
HRT trial demonstrates improved memory function in adrenal patients
Better timing for cortisol replacement therapies, to more closely replicate the secretion patterns of people with normal levels of the hormone, has shown a significant improvement in patients' cognitive function...
Adhesive patch offers bloodless diabetes monitoring
Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test...
Study examines antipsychotic medication for children with autism
Children with intellectual difficulty or autism are more likely to be given antipsychotic medication from a younger age than those without intellectual disability...
Sirolimus gel provides breakthrough treatment for tuberous sclerosis complex
Scientists have developed a new drug treating skin lesions in tuberous sclerosis complex (TSC), a rare intractable disease...
How did gonorrhoea become a drug-resistant superbug?
Scientists show how the gonorrhoea bacterium resists last-resort antibiotic ceftriaxone while maintaining a robust growth rate...
